Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

NCT02164071 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02164071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02164071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
April 11, 2012
Completion date
July 4, 2015
Enrollment
363 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia myeloid acute, leuklemia, lymphocytic, chronic, multiple myeloma, myelodysplastic syndromes